Advertisement
U.S. markets open in 2 hours 45 minutes

China SXT Pharmaceuticals, Inc. (SXTC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.3904+0.0002 (+0.05%)
At close: 04:00PM EST
0.4003 +0.01 (+2.54%)
Pre-Market: 04:43AM EST
Advertisement
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,928
1,928
1,972
2,602
4,778
Cost of Revenue
1,375
1,375
1,545
1,351
1,938
Gross Profit
553.971
553.971
426.271
1,252
2,840
Operating Expense
3,069
3,069
6,034
6,441
5,037
Operating Income
-2,515
-2,515
-5,608
-5,190
-2,197
Net Non Operating Interest Income Expense
-544.279
-544.279
-476.776
-36.695
-1,615
Other Income Expense
-39.036
-39.036
149.513
-181.581
871.65
Pretax Income
-3,099
-3,099
-5,935
-5,408
-2,941
Tax Provision
0
0
0
328.146
-192.683
Net Income Common Stockholders
-3,099
-3,099
-5,935
-5,736
-2,748
Diluted NI Available to Com Stockholders
-3,099
-3,099
-5,935
-5,736
-2,748
Basic EPS
-22.23
-3.57
-22.23
-137.92
-95.47
Diluted EPS
-22.23
-3.57
-22.23
-137.92
-95.47
Basic Average Shares
266.973
867.422
266.973
41.591
28.781
Diluted Average Shares
266.973
867.422
266.973
41.591
28.781
Total Operating Income as Reported
-2,515
-2,515
-5,608
-5,190
-2,197
Total Expenses
4,444
4,444
7,579
7,792
6,975
Net Income from Continuing & Discontinued Operation
-3,099
-3,099
-5,935
-5,736
-2,748
Normalized Income
-3,099
-3,099
-5,935
-5,736
-2,748
Interest Expense
544.279
544.279
476.776
36.695
-
Net Interest Income
-544.279
-544.279
-476.776
-36.695
-1,615
EBIT
-2,554
-2,554
-5,458
-5,371
-2,197
EBITDA
-2,351
-2,351
-5,208
-5,051
-1,852
Reconciled Cost of Revenue
1,375
1,375
1,545
1,351
1,938
Reconciled Depreciation
203.247
203.247
250.162
320.007
345.414
Net Income from Continuing Operation Net Minority Interest
-3,099
-3,099
-5,935
-5,736
-2,748
Total Unusual Items Excluding Goodwill
-
-
-
0
0
Total Unusual Items
-
-
-
0
0
Normalized EBITDA
-2,351
-2,351
-5,208
-5,051
-1,852
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0